Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria T Voso

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Opinion in Oncology|September 16, 2011
Therapy-related myeloid neoplasmsGiuseppe Leone, Luana Fianchi, Maria T Voso
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 25, 2003
Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome after bupropion treatment for smoking cessationLuca Mele, Maria T Voso, Luana Fianchi, et al.
British Journal of Haematology|March 31, 2015
Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphomaValentina Bozzoli, Maria C Tisi, Elena Maiolo, et al.
The Journal of Molecular Diagnostics : JMD|December 3, 2014
Development of a high-resolution melting curve analysis screening test for SRSF2 splicing factor gene mutations in myelodysplastic syndromesEduardo Garza, Emiliano Fabiani, Nelida Noguera, et al.
Cancer Medicine|January 14, 2016
CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphomaAnnarosa Cuccaro, Salvatore Annunziata, Elisa Cupelli, et al.
Future Oncology (London, England)|January 20, 2016
Design of the randomized, Phase III, QUAZAR AML Maintenance trial of CC-486 (oral azacitidine) maintenance therapy in acute myeloid leukemiaGail J Roboz, Pau Montesinos, Dominik Selleslag, et al.
British Journal of Haematology|April 19, 2017
Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre studyPellegrino Musto, Luca Maurillo, Vittorio Simeon, et al.
The New England Journal of Medicine|May 25, 2022
Demethylation and Up-Regulation of an Oncogene after Hypomethylating TherapyYao-Chung Liu, Junsu Kwon, Emiliano Fabiani, et al.
British Journal of Haematology|October 20, 2022
Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemiaDiego A Pereira-Martins, Juan L Coelho-Silva, Isabel Weinhäuser, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Opinion in Oncology|September 16, 2011
Therapy-related myeloid neoplasmsGiuseppe Leone, Luana Fianchi, Maria T Voso
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 25, 2003
Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome after bupropion treatment for smoking cessationLuca Mele, Maria T Voso, Luana Fianchi, et al.
British Journal of Haematology|March 31, 2015
Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphomaValentina Bozzoli, Maria C Tisi, Elena Maiolo, et al.
The Journal of Molecular Diagnostics : JMD|December 3, 2014
Development of a high-resolution melting curve analysis screening test for SRSF2 splicing factor gene mutations in myelodysplastic syndromesEduardo Garza, Emiliano Fabiani, Nelida Noguera, et al.
Cancer Medicine|January 14, 2016
CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphomaAnnarosa Cuccaro, Salvatore Annunziata, Elisa Cupelli, et al.
Future Oncology (London, England)|January 20, 2016
Design of the randomized, Phase III, QUAZAR AML Maintenance trial of CC-486 (oral azacitidine) maintenance therapy in acute myeloid leukemiaGail J Roboz, Pau Montesinos, Dominik Selleslag, et al.
British Journal of Haematology|April 19, 2017
Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre studyPellegrino Musto, Luca Maurillo, Vittorio Simeon, et al.
The New England Journal of Medicine|May 25, 2022
Demethylation and Up-Regulation of an Oncogene after Hypomethylating TherapyYao-Chung Liu, Junsu Kwon, Emiliano Fabiani, et al.
British Journal of Haematology|October 20, 2022
Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemiaDiego A Pereira-Martins, Juan L Coelho-Silva, Isabel Weinhäuser, et al.
Pageof 1